Cancer Research UK Cambridge Institute The Cancer Research UK Cambridge Institute (CRUK CI) was officially opened by Queen Elizabeth II in February 2007 and has excellent state of the art facilities. The Cancer Research UK Cambridge Institute is a joint venture between the Charity, Cancer Research UK, and the University of Cambridge. CRUK CI housed in the Li Ka Shing Centre, focuses on tackling questions relating to cancer diagnosis, treatment and prevention, supported by world-class core scientific facilities. The University is ranking in worlds 4th place for its best services and research practices. The Institute’s main aim is to be a focus for the practical application of high-quality basic research, forming a bridge between the world-class science of the University of Cambridge and its environment, and Addenbrookes Hospital. The University of Cambridge is a major member institute of the Cambridge Cancer Centre, a virtual organisation of Cambridge researchers whose work has current or potential application to cancer research. The Institute offers highly competitive PhD programmes; both studentships and clinical research training fellowships (for aspiring clinical academics), attracting applicants from the UK and around the world. Cancer research is a designated University of Cambridge Strategic Initiative. There are around 22 research groups and a list of around 150 researchers and approximately 60 graduate students are at the CRUK CI, approximately 1/3 are from the UK, 1/3 are from the EU and 1/3 are from further afield. Graduate students play pivotal roles in the continuing success of our research programmes and gaining a studentship in the Institute is an excellent opportunity to start a research career in an environment committed to training outstanding cancer research scientists of the future. CRUK-CI is home to four main areas of research: • Basic research, which involves looking into the cellular and molecular biology of cancer. • Research into molecular imaging, genomics, bioinformatics and biomolecular modeling. • Research that focuses on specific cancer sites, forming a bridge between the clinical and laboratory areas. • Clinical investigations and trials, including population based studies into screening and prevention. The University and CRUK CI value diversity and are committed to equality of opportunity.